Posted On: 01/09/2015 4:39:57 PM
Post# of 30066
Re: Daveludlow #14628
Good response, Dave.
I am expecting more than just Lympro data next week. GC owes us that much after several months of stringing us along with final Lympro numbers.
Hopefully I am not expecting too much, but I know more Lympro data, without proof of revenue, will not move the share price. Unless the spec/sen numbers are high 90s. That might be a different story I suppose.
I am expecting more than just Lympro data next week. GC owes us that much after several months of stringing us along with final Lympro numbers.
Hopefully I am not expecting too much, but I know more Lympro data, without proof of revenue, will not move the share price. Unless the spec/sen numbers are high 90s. That might be a different story I suppose.
(0)
(0)
